Inhibiting the Jumonji family: A potential new clinical approach to targeting aberrant epigenetic mechanisms

Elisabeth D. Martinez, Adi F. Gazdar

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)313-316
Number of pages4
JournalEpigenomics
Volume8
Issue number3
DOIs
StatePublished - Mar 1 2016

Keywords

  • cancer
  • epigenetic reprogramming
  • epigenetic therapy
  • histone demethylation
  • Jumonji family
  • Jumonji inhibitors
  • lysine demethylation

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this